Generic Name and Formulations:
Fenoprofen calcium 200mg; caps.
Company:
Pedinol Pharmacal, Inc.
Rheumatoid arthritis. Osteoarthritis.
300mg–600mg 3 or 4 times daily. Max: 3.2g/day.
<18yrs: not recommended.
NSAID (arylacetic acid deriv.).
Aspirin allergy. CABG surgery. Significant renal impairment. 3rd trimester pregnancy.
Hypertension. CHF. Edema. History of ulcer disease or GI bleeding. Hearing impaired. Asthma. Monitor blood, hepatic, renal, and ocular function in chronic use. Elderly. Debilitated. Pregnancy (Cat.C). Nursing mothers: not recommended.
Avoid aspirin. May potentiate protein-bound drugs (eg, hydantoins, sulfonamides, sulfonylureas). May antagonize ACE-inhibitors, diuretics. May be antagonized by phenobarbital. Increased risk of GI bleed with oral corticosteroids, anticoagulants (monitor), alcohol, smoking. Methotrexate excretion reduced. Increases lithium levels.
GI upset, dyspepsia, constipation, tremor, confusion, increased sweating, pruritus, rash (discontinue if occurs), tinnitus, blurred vision, decreased hearing, palpitations, nervousness, asthenia, peripheral edema, dyspnea; GI ulcer/bleed, elevated liver enzymes (discontinue if hepatotoxicity develops), blood dyscrasias, renal papillary necrosis. See literature re: risk of cardiovascular events.
Caps—100
Mild to moderate pain.
200mg every 4–6hrs as needed.
<18yrs: not recommended.
NSAID (arylacetic acid deriv.).
Aspirin allergy. CABG surgery. Significant renal impairment. 3rd trimester pregnancy.
Hypertension. CHF. Edema. History of ulcer disease or GI bleeding. Hearing impaired. Asthma. Monitor blood, hepatic, renal, and ocular function in chronic use. Elderly. Debilitated. Pregnancy (Cat.C). Nursing mothers: not recommended.
Avoid aspirin. May potentiate protein-bound drugs (eg, hydantoins, sulfonamides, sulfonylureas). May antagonize ACE-inhibitors, diuretics. May be antagonized by phenobarbital. Increased risk of GI bleed with oral corticosteroids, anticoagulants (monitor), alcohol, smoking. Methotrexate excretion reduced. Increases lithium levels.
GI upset, dyspepsia, constipation, tremor, confusion, increased sweating, pruritus, rash (discontinue if occurs), tinnitus, blurred vision, decreased hearing, palpitations, nervousness, asthenia, peripheral edema, dyspnea; GI ulcer/bleed, elevated liver enzymes (discontinue if hepatotoxicity develops), blood dyscrasias, renal papillary necrosis. See literature re: risk of cardiovascular events.
Caps—100